about neuroVasix
As a privately owned company with the EXCLUSIVE MARKETING RIGHTS TO THE MICROVAS TECHNOLOGY, it has sold and supports almost 1,000 systems in many markets, having sold systems to medical doctors, osteopathic physicians, podiatrists, physical therapists, various clinics, hospitals, veteran homes, nursing homes, professional athletes and professional sports teams. As neuroVasix expands its sales, each of these markets will continue to be of significant importance. Currently, management is focusing its sales efforts in three major areas: treatment of neuropathy, treatment of wounds, and podiatry.
about the MicroVas system
a patented, FDA 510-K registered, non-invasive device that delivers a unique, biphasic, faradic, high voltage electrical current to targeted areas of the human body. This powerful, deeply penetrating, electrical waveform, causes blood to pump more efficiently through the micro circulation (drain the venous beds and raise tissue oxygen levels) in damaged tissue to accelerate the healing process.
The therapeutic effects are dramatic and lasting.
Healthcare professionals familiar with it consider it an important new tool in the treatment of neuropathy, non-healing wounds, repetitive motion disorders, fibromyalgia, sports injuries and many other conditions related to vascular insufficiency.
NOTE: THERE IS ONLY ONE VERSION OF THE MICROVAS. NOTHING ELSE.
OTHERS MAY CLAIM TO HAVE A "NEWER OR BETTER VERSION", BUT THERE IS NOT.
NEUROVASIX WILL PURSUE ALL LEGAL REMEDIES TO PROTECT ITS RIGHTS.
